bobbybobby
FeatureMarketsStocks

The Hartford

HIG

$139.61

+1.09%

The Hartford Insurance Group, Inc. is a leading provider of property and casualty insurance, group benefits, and mutual funds, operating within the diversified insurance sector of financial services. The company has established a strong competitive identity as a trusted, service-excellent provider known for its sustainability practices and integrity, with its Business Insurance segment generating the majority of revenue. The current investor narrative centers on the company's ability to navigate the insurance underwriting cycle, with recent financial performance showing robust profitability and growth, which is likely driving attention toward its capital return capabilities and disciplined margin management in a potentially volatile interest rate environment.…

Should I buy HIG
Bobby Quantitative Model
Apr 23, 2026

HIG

The Hartford

$139.61

+1.09%
Apr 23, 2026
Bobby Quantitative Model
The Hartford Insurance Group, Inc. is a leading provider of property and casualty insurance, group benefits, and mutual funds, operating within the diversified insurance sector of financial services. The company has established a strong competitive identity as a trusted, service-excellent provider known for its sustainability practices and integrity, with its Business Insurance segment generating the majority of revenue. The current investor narrative centers on the company's ability to navigate the insurance underwriting cycle, with recent financial performance showing robust profitability and growth, which is likely driving attention toward its capital return capabilities and disciplined margin management in a potentially volatile interest rate environment.
Should I buy HIG

People also watch

Berkshire Hathaway Inc.

Berkshire Hathaway Inc.

BRK-B

Analysis
American International Group

American International Group

AIG

Analysis
Principal Financial Group

Principal Financial Group

PFG

Analysis
Equitable Holdings

Equitable Holdings

EQH

Analysis
Fundrise Innovation Fund, LLC

Fundrise Innovation Fund, LLC

VCX

Analysis

HIG 12-Month Price Forecast

Historical Price
Current Price $139.61
Average Target $139.61
High Target $160.5515
Low Target $118.66850000000001

Wall Street consensus

Most Wall Street analysts maintain a constructive view on The Hartford's 12-month outlook, with a consensus price target around $181.49 and implied upside of +30.0% versus the current price.

Average Target

$181.49

3 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

3

covering this stock

Price Range

$112 - $181

Analyst target range

Buy
0 (0%)
Hold
1 (33%)
Sell
2 (67%)

Analyst coverage for Hartford appears limited in the provided dataset, with only 3 analysts providing estimates for revenue and EPS, and no explicit consensus price target, recommendation, or target range data is available. The estimated EPS average for the upcoming period is $15.80, with a range from $15.26 to $16.34, indicating a relatively tight spread and consensus on near-term earnings power. Given the lack of explicit price targets and the low analyst count, coverage can be considered insufficient for deriving a strong market consensus. This is somewhat surprising for a company of Hartford's size ($38.9B market cap) and suggests it may be under-followed by the broader analyst community. The recent institutional ratings show a mix of actions, including a downgrade from Keefe, Bruyette & Woods from 'Outperform' to 'Market Perform' in late March 2026, alongside maintained 'Overweight' and 'Neutral' ratings from other firms, reflecting a neutral-to-cautiously optimistic stance among those who do cover it.

Drowning in data?

Find the real signal!

Chat Now

Drowning in data?

Find the real signal!

Chat Now

Bulls vs Bears: HIG Investment Factors

The bull case, grounded in exceptional fundamental strength, currently holds stronger evidence. The sequential quarterly improvement in revenue, a near-doubling of net income, massive free cash flow generation, and a valuation near the low end of its historical range create a compelling value proposition. The primary tension in the investment debate is whether the company's peak profitability and margins, demonstrated in Q4 2025, are sustainable within the cyclical insurance industry, or if they represent a cyclical high that will normalize, compressing the current attractive valuation multiples. The resolution of this tension—through either sustained margin discipline or a cyclical downturn—will be the most important driver of the stock's direction.

Bullish

  • Strong Profitability & Margin Expansion: Q4 2025 net income of $1.131 billion represents a 78% sequential increase from Q1 2025, with net margin expanding from 9.25% to 15.47%. Gross margin improved from 41.26% to 48.95% over the same period, demonstrating significant operating leverage and disciplined underwriting.
  • Robust Revenue Growth Trajectory: Revenue grew 7.53% YoY in Q4 2025 to $7.312 billion, marking the fourth consecutive quarter of sequential growth from $6.81B in Q1. This consistent acceleration from $6.81B to $7.312B throughout 2025 indicates strong pricing power and demand in its core Business Insurance segment.
  • Exceptional Financial Strength & Capital Return: The company boasts a fortress balance sheet with a debt-to-equity ratio of 0.23 and a current ratio of 17.65. This supports aggressive shareholder returns, evidenced by $1.215B in stock repurchases and $151M in dividends paid in Q4 2025 alone, funded by $5.753B in TTM free cash flow.
  • Attractive Valuation Relative to History: The stock trades at a trailing PE of 10.14x, which is near the lower end of its historical range observed in the data (6.05x to 24.02x). This suggests the stock is not priced for overly optimistic expectations, offering a relative value opportunity given the current high profitability (20.21% ROE).

Bearish

  • Limited Analyst Coverage & Sentiment: Only 3 analysts provide estimates, indicating the stock is under-followed for its $38.9B market cap. Recent institutional ratings include a downgrade to 'Market Perform' from Keefe, Bruyette & Woods, reflecting a neutral-to-cautious stance and potential lack of catalyst visibility.
  • Proximity to 52-Week High Resistance: Trading at $139.84 places the stock at approximately 97% of its 52-week high of $144.50. This proximity to a key technical resistance level, combined with a recent 12.04% max drawdown from the February peak, suggests near-term upside may be limited without a decisive breakout.
  • Cyclical Exposure to Insurance Underwriting: As a P&C insurer, HIG's profitability is inherently tied to the insurance underwriting cycle. While current margins are strong, a turn in the cycle marked by increased catastrophe losses or competitive pricing pressure could reverse the impressive margin expansion seen in 2025.
  • Modest Growth Expectations Priced In: The forward PE of 9.65x is only a slight discount to the trailing PE of 10.14x, indicating the market anticipates only modest earnings growth. The estimated EPS range for the upcoming period is tight ($15.26 to $16.34), suggesting consensus expects stability rather than acceleration.

HIG Technical Analysis

The stock is in a sustained uptrend, evidenced by a 1-year price change of +18.71%, and is currently trading at approximately 97% of its 52-week high of $144.50, indicating strong momentum but also proximity to a key resistance level. With a current price of $139.84, the stock has gained 5.37% over the past month and 7.91% over the past three months, showing accelerating short-term momentum that aligns with the longer-term bullish trend. The stock's beta of 0.528 indicates it is approximately 47% less volatile than the broader market (SPY), which is significant for risk-averse investors seeking defensive exposure within an uptrend. Recent momentum is robust, with the 1-month return of +5.37% and 3-month return of +7.91% both outpacing the SPY's returns over the same periods, which were +7.36% and +2.67%, respectively. This positive relative strength, particularly the +5.24 relative strength over 3 months, suggests the stock is not only rising but outperforming the market, reinforcing the bullish trend rather than signaling a divergence or pullback. The price action from the provided data shows a clear recovery from a low near $128.80 in late January 2026 to recent highs, confirming the momentum's sustainability. Key technical support is at the 52-week low of $113.27, while immediate resistance is at the 52-week high of $144.50. A decisive breakout above $144.50 would signal a continuation of the uptrend and potentially open the path for further gains, while a breakdown below the recent consolidation range near $135 would suggest a loss of momentum. The stock's low beta of 0.528 implies it experiences smaller price swings than the market, which, combined with a low short ratio of 0.05, suggests limited bearish sentiment and a stable technical foundation for the current uptrend.

Beta

0.53

0.53x market volatility

Max Drawdown

-12.0%

Largest decline past year

52-Week Range

$117-$145

Price range past year

Annual Return

+17.3%

Cumulative gain past year

PeriodHIG ReturnS&P 500
1m+3.1%+8.5%
3m+8.5%+2.8%
6m+11.6%+4.6%
1y+17.3%+32.3%
ytd+1.8%+3.9%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now

HIG Fundamental Analysis

Hartford's revenue trajectory is solidly positive, with Q4 2025 revenue of $7.312 billion representing a 7.53% year-over-year growth. This growth has been consistent through 2025, with sequential quarterly revenues of $6.81B, $6.987B, $7.232B, and $7.312B, indicating a steady acceleration. The company's primary driver is its Business Insurance segment, and this multi-quarter revenue climb from $6.81 billion in Q1 to $7.312 billion in Q4 underscores a healthy demand environment and effective pricing power. The company is highly profitable, with Q4 2025 net income of $1.131 billion and a net margin of 15.47%. Gross margin for the quarter was a strong 48.95%, and the operating margin was 19.32%. Profitability has improved markedly through 2025, as evidenced by net income rising from $630 million in Q1 to $1.131 billion in Q4, and gross margin expanding from 41.26% to 48.95% over the same period. This demonstrates significant operating leverage and effective cost management within the insurance underwriting cycle. Hartford's balance sheet is exceptionally strong, with a low debt-to-equity ratio of 0.23 and a remarkably high current ratio of 17.65, indicating ample liquidity. The company generates substantial cash, with trailing twelve-month free cash flow of $5.753 billion. This strong cash generation, coupled with a return on equity of 20.21%, shows the company is efficiently using shareholder capital and has significant capacity for shareholder returns, such as the $1.215 billion in stock repurchases and $151 million in dividends paid in Q4 2025 alone.

Quarterly Revenue

$7.3B

2025-12

Revenue YoY Growth

+0.07%

YoY Comparison

Gross Margin

+0.48%

Latest Quarter

Free Cash Flow

$5.8B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Property, Liability and Casualty Insurance Product Line

Open an Account, get $2 TSLA now!

Open Account Now

Open an Account, get $2 TSLA now!

Open Account Now

Valuation Analysis: Is HIG Overvalued?

Given Hartford's substantial net income of $1.131 billion, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 10.14x and a forward PE of 9.65x. The slight discount of the forward multiple suggests the market anticipates modest earnings growth, but the narrow gap indicates expectations are relatively stable, not aggressive. Compared to typical financial services or insurance peers, Hartford's trailing PE of 10.14x appears reasonable, though a direct industry average from the provided data is not available for comparison. The stock's Price-to-Sales ratio of 1.38x and Price-to-Book ratio of 2.05x provide additional context, suggesting the market is valuing the company at a moderate premium to its book value, which is justified by its high return on equity of 20.21% and strong profitability profile. Historically, Hartford's current trailing PE of 10.14x sits below its own historical range observed in the data, which has seen quarterly PE ratios fluctuate between approximately 6.05x and 24.02x over the past several years. Positioning near the lower end of this multi-year band suggests the stock is not priced for overly optimistic expectations and may offer a relative value opportunity if the company's fundamental strength persists, especially compared to periods where the PE exceeded 14x during less profitable quarters.

PE

10.1x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 6x~24x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

8.1x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: Hartford's primary financial risk is not leverage or liquidity—its balance sheet is exceptionally strong—but rather the sustainability of its current peak profitability. The net margin expanded dramatically from 9.25% in Q1 2025 to 15.47% in Q4. A reversion toward the mean, driven by an increase in claims severity (catastrophe losses) or competitive pricing pressure, could significantly compress earnings. While revenue is diversified across segments, the Business Insurance unit generates the majority, creating some concentration risk. The company's valuation (PE of 10.14x) and generous capital returns are dependent on maintaining these elevated earnings levels.

Market & Competitive Risks: The stock trades at 97% of its 52-week high, introducing valuation compression risk if it fails to break through this resistance. Its low beta of 0.528 offers defensive characteristics but also means it may lag in strong bull markets, as evidenced by its 16.19% underperformance versus the SPY over the past year. The insurance sector is highly competitive and regulated, and any regulatory changes impacting underwriting or capital requirements could affect profitability. The limited analyst coverage (only 3) suggests the stock could be more susceptible to sentiment shifts based on single data points, such as a quarterly earnings miss.

Worst-Case Scenario: The most damaging scenario involves a simultaneous hardening of the insurance underwriting cycle and a significant market downturn. This would manifest as a surge in catastrophe losses compressing margins back toward Q1 2025 levels (~9%), combined with a broad market sell-off that disproportionately impacts financial stocks. In this adverse scenario, the stock could realistically retreat to its 52-week low of $113.27, representing a downside of approximately -19% from the current price of $139.84. A drawdown to this level would be consistent with the stock's observed max drawdown of -12.04% from recent highs and historical volatility within the insurance sector.

People also watch

Berkshire Hathaway Inc.

Berkshire Hathaway Inc.

BRK-B

Analysis
American International Group

American International Group

AIG

Analysis
Principal Financial Group

Principal Financial Group

PFG

Analysis
Equitable Holdings

Equitable Holdings

EQH

Analysis
Fundrise Innovation Fund, LLC

Fundrise Innovation Fund, LLC

VCX

Analysis

Product

Partner

Markets

Stocks

© 2026 Flow AI Limited. All Rights Reserved.

Bobby, the world's first financial AI Agent, is developed by Flow AI, an AI-driven company. Flow AI is dedicated to providing global investors with AI-powered financial services across multiple markets.

Bobby
Bobby AI
RockFlow Platform
Stock Event
Macro Event
Industry Event
NVDA
AAPL
MSFT
AMZN
GOOG
META
TSLA
Privacy Policy
Terms of Use